Researchers found that the Mead Johnson formula group had fewer episodes, with a shorter average duration, of acute respiratory infections compared to control.
A Mead Johnson milk-based product containing omega-3 fatty acid DHA, a prebiotic blend of polydextrose (PDX) and galactooligosaccharides (GOS), and a yeast beta-glucan reduced incidence of acute respiratory infections in children. Mead Johnson presented the results of its study at the recent Experimental Biology conference in Boston.
The double-blind, randomized, controlled trial took place over 28 weeks. Subjects were 310 healthy children aged 3-4 years, who were administered three servings/day of the Mead Johnson milk-based formula. The formula contained 25 mg/serving DHA, 1.2 g/serving PDX and GOS, and 12.8 mg/serving of yeast Wellmune beta-glucans from supplier Biothera (Eagan, MN). The control group received powdered cow’s milk.
Researchers found that the Mead Johnson formula group had fewer episodes, with a shorter average duration, of acute respiratory infections compared to control.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.